Trade HBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Harvard Bioscience, Inc. (HBIO) is trading at US$8.07, up 1.52% today as of Sep 21, 10:43 EDT. The company has a market capitalisation of US$34.05M. Over the past 52 weeks, HBIO has traded between US$3.76 and US$9.40. On Syfe you can trade HBIO with $0 commission and add it to your watchlist.
| Previous close | US$7.95 |
|---|---|
| Market cap | US$34.05M |
| P/E ratio | 22.33 |
| 52-week range | US$3.76 – US$9.40 |
| Volume | 19.22K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Year: 2000
Harvard Bioscience, Inc. (HBIO) stock is trading at US$8.07, +1.52% from the previous close of US$7.95.
The market cap for Harvard Bioscience, Inc. (HBIO) stock is approximately US$34.05M.
The price-to-earnings ratio for Harvard Bioscience, Inc. (HBIO) is 22.33, based on the latest reported earnings.
The 52-week high for Harvard Bioscience, Inc. (HBIO) stock is US$9.40.
The 52-week low for Harvard Bioscience, Inc. (HBIO) stock is US$3.76.
Harvard Bioscience, Inc. (HBIO) does not currently pay a dividend.
Stay on top of HBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
